US2005037468A1PendingUtilityA1
Pain signaling molecules
Priority: May 4, 2000Filed: Sep 30, 2004Published: Feb 17, 2005
Est. expiryMay 4, 2020(expired)· nominal 20-yr term from priority
G01N 2333/726G01N 33/5082A61K 38/00G01N 33/5058C07K 14/70571C07K 14/705G01N 2500/02G01N 33/5041G01N 33/54366
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates generally to novel genes expressed in normal but not Neurogenin-1-deficient animals. The invention relates specifically to a novel family of G protein-coupled receptors and a novel family of two-transmembrane segment proteins that are expressed in dorsal root ganglia, and a method of screening for genes specifically expressed in nociceptive sensory neurons.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid molecule encoding a G protein coupled receptor and comprising a sequence having at least 70% sequence identity to (1) the nucleic acid molecule of SEQ ID NO: 34, or (2) the complement of the nucleic acid molecule of (1).
2 . An isolated nucleic acid molecule that hybridizes under stringent conditions to the isolated nucleic acid molecule of claim 1 .
3 . The isolated nucleic acid molecule of claim 1 operably linked to an expression control element.
4 . The isolated nucleic acid molecule of claim 3 operably linked to a promoter element.
5 . A vector comprising the isolated nucleic acid molecule of claim 4 .
6 . A host cell comprising the vector of claim 5 .
7 . The host cell of claim 6 wherein said host cell is a prokaryotic cell.
8 . The host cell of claim 7 wherein said host cell is an E. coli.
9 . The host cell of claim 6 wherein said host cell is a eukaryotic cell.
10 . The host cell of claim 9 wherein said host cell is a hamster embryonic kidney (HEK) cell.
11 . The host cell of claim 9 wherein said host cell is a yeast cell.
12 . A method for producing an MrgD polypeptide comprising culturing the host cell of claim 6 under conditions in which the protein encoded by said nucleic acid is expressed.
13 . An isolated nucleic acid molecule according to claim 1 having at least 80% sequence identity to (1) the nucleic acid molecule of SEQ ID NO: 34, or (2) the complement of the nucleic acid molecule of (1).
14 . An isolated nucleic acid molecule according to claim 1 having at least 90% sequence identity to (1) the nucleic acid molecule of SEQ ID NO: 34, or (2) the complement of the nucleic acid molecule of (1).
15 . An isolated nucleic acid molecule that encodes a G protein coupled receptor and comprises a sequence having at least 95% sequence identity to (1) the nucleic acid molecule of SEQ ID NO: 34, or (2) the complement of the nucleic acid molecule of (1).
16 . An isolated nucleic acid molecule comprising a sequence having at least 99% sequence identity to (1) the nucleic acid molecule of SEQ ID NO: 34, or (2) the complement of the nucleic acid molecule of (1).
17 . The isolated nucleic acid molecule of claim 16 operably linked to an expression control element.
18 . A vector comprising the isolated nucleic acid molecule of claim 16 .
19 . A host cell comprising the vector of claim 18 .
20 . The host cell of claim 18 , wherein the host cell is selected from the group consisting of eurkaryotic cells and prokaryotic cells.Join the waitlist — get patent alerts
Track US2005037468A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.